Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects; hGH

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleSafety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects; hGH
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date18/10/2
    PersonsSoo Hyun Park